Want to learn how to better utilize University’s Tech Transfer offices to gain access to new cutting edge technology and be able to implement it in your company?
Universities are the source of disruptive technology. However, it can be difficult to find the new inventions within a university. The process is called Tech Transfer and each research-intensive university has a Tech Transfer Office that protects the inventions and tries to find companies to license the new intellectual property. Each office works differently with its own set of resources, goals and internal processes to work with industry. This IF Talk will introduce you to regional Tech Transfer Offices and provide insight into how to work with them, including finding the right innovations for your company, how to negotiate and complete transactions on your time frame, and how to make the most of your local universities.
Check out the bios of our panel speakers:
David Snow from Texas Tech University
Dr. Snow was appointed senior managing director of the Office of Research Commercialization in Aug. 2016. In this role, he is responsible for intellectual property, licensing, and venture development activity across all Texas Tech campuses, which include Texas Tech University, Angelo State University, Texas Tech Health Sciences Centers, and the TTUHSC Paul L. Foster School of Medicine in El Paso. As a licensed patent agent, he continues as the Managing Director of Intellectual Property serving the Texas Tech University System, and is responsible for the assessment, protection, and management of the intellectual property portfolio. He also manages the Technology Review Team, IP Committee, and relations with external patent firms.
As an entrepreneur, Dr. Snow launched a startup company that offers consultation and marketing support for biotechnology and clinical diagnostic providers developing research concepts into marketable products. Additionally, Dr. Snow has served in varying capacities in four other start-ups since 2008, two of which are businesses operating outside the technical space.
Claire Aldridge from UT Southwestern
Claire Aldridge, Ph.D. serves as Associate Vice President for Commercialization and Business Development at UT Southwestern Medical Center. She recently rejoined UT Southwestern after eight years with Remeditex Ventures, a local biotech venture fund. Dr. Aldridge brings more than 20 years’ experience facilitating the translation of scientific discoveries into patient and commercial benefits. Dr. Aldridge has leveraged her training as a translator, or liaison, between scientists and non- scientists, communicating effectively about the potential of science. Her roles have included technology commercialization; improving patient outcomes through quality based initiatives; working with disease-specific nonprofits; development and venture philanthropy; and biotech and life science investing through venture capital.
In addition to broadening the pipeline of commercialization opportunities for UT Southwestern discoveries, she plans to bring her science communication, commercialization and venture capital skills together with other science and civic leaders to grow and more deeply establish a biotech ecosystem in the North Texas region. Dr. Aldridge received her Ph.D. from Duke University in the Department of Immunology and Program in Genetics, and her Bachelor of Science in Biomedical Science is from Texas A&M University.
Michael Rondelli from University of North Texas
Michael Rondelli is UNT associate vice president for innovation and commercialization, having previously directed licensing and commercialization at the University of Southern California’s Stevens Center for Innovation and led technology transfer and commercialization efforts at San Diego State University. Prior to his work for universities, Rondelli worked as a venture capitalist and banking analyst. He earned a law degree from the University of San Diego, a master’s degree in business administration from Texas Christian University and a bachelor’s degree in marketing from Washington University in St. Louis.
Teri Schultz from UT Arlington
Teri has been director of Innovation & Commercialization (formerly Office of Technology Management) at UTA for over 6 years. Teri also manages the StartUp Lounge at UTA, a collision space for faculty, student, staff and community entrepreneurs to come together to work on their business ideas. With partner TechFW, she developed an entrepreneurship workshop series, EpICMavs, held at the StartUp Lounge weekly during the semester and for 7 weeks during the summer.
A patent attorney by training, Teri worked in the IP legal department at Alcon Laboratories for 12 years prior to joining UTA. At Alcon, Teri managed a patent portfolio, counseled the clinical group on all aspects of clinical studies including all types of clinical study agreements, negotiated numerous IP agreements and assisted the business development group in conducting due diligence with respect to potential licenses and acquisitions. She began her career as a patent attorney in the Austin office of Arnold, White & Durkee (now NortonRoseFulbright).